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SUMMARY Ingestion of the rat poison N-3-pyridylmethyl-N'-p-nitrophenylurea (PNU) produced ocular toxicity in three humans and in an animal model, the Dutch Belted rabbit. The electroretinogram b wave was especially susceptible to the effects of the rodenticide, and the target tissue appeared to be the retinal pigment epithelium. Injection of PNU itself did not produce ocular toxicity. The poison had to be administered orally. Gentamicin administered orally with PNU prevented the ocular toxicity. Presumably this antibiotic killed those gastrointestinal bacteria responsible for PNU's metabolism into an ocular toxin. L-tryptophan, a known antidote for the lethal effects of PNU, was an antidote for the ocular toxicity when administered orally but not when administered parenterally.
N-3-pyridylmethyl-N'-p-nitrophenylurea (Vacor, PNU) is a rat poison that attacks peripheral nerves and the P cells of the pancreas. 12 It seems to have a low toxicity for pets and primates. While the LD,_, for rats was 12 mg/kg, those for dogs and rhesus monkeys were more than 500 mg/kg and 2000 mg/kg respectively. Unfortunately PNU was found to be much more toxic in humans than expected; the LD50 for man has been estimated at 5 to 10 mg/kg. The minimum lethal total dose reported in an adult male was between 390 and 780 m.' The nucleotide precursors, L-tryptophan and nicotinamide, were found to be effective antidotes in rats;4 nicotinamide became the recommended treatment of human poisoning. ' Diabetes mellitus was a common finding in human survivors. fP Cell function tended to return to a variable degree two to three years after ingesting the poision.6 PNU also produced human peripheral neuropathy and encephalopathy.7 Orthostatic hypotension tended to be the most persistent and troublesome abnormality, though full recovery has been reported!. increasing doses in an attempt to control her orthostatic hypotension. At a daily dose of 6 mg a day of ergotamine tartrate the patient's symptoms were controlled (blood pressure 130/70 mmHg supine and 120/75 mmHg standing). However, after three weeks of being maintained at this dosage she complained of severe head pain and mildly blurred vision. Ergotamine tartrate was discontinued. Three weeks later, and approximately eight months after her first ophthalmic examination, she was again examined.
Her visual acuity remained 6/6 in each eye, but the arterioles and venules of the retinas were now threadlike. Fluorescein angiography showed decreased vascularity of the optic disc and a tessellated pigmented epithelium. There was no abnormal retinal pigment clumping. Electroretinograms were extinguished bilaterally. Retinal thresholds after dark adaptation were markedly elevated in the peripheral retina but only moderately in the posterior pole. The findings on this point were reported in greater detail in 1981.9 At that time it was assumed that the cause of the retinal changes between the two eye examinations was the ergotamine tartrate. During the next three years she developed a progressive pigment retinopathy (Fig. 1) . Mild opacifications and pigment accumulations were seen on the posterior lens capsules (Fig. 2) . Her visual acuities were reduced to 6/7-5 bilaterally.
To help clarify the role of PNU in producing this progressive retinopathy, other survivors of Vacor (Fig. 3) . The scotopic response to the weak stimulus was subnormal in amplitude and delayed in implicit time (80 to 85 ms). The scotopic response to the strong stimulus consisted only of a decreased amplitude a wave with a longer than normal latency. Under photopic conditions, the amplitude of the b wave to the flicker stimulus was about half the size of the normal recording, with a slight delay in the implicit time (34 ms).
Patient 3 was a 32-year-old white male who had ingested 1-5 g of PNU six years previously. A more complete description of his case history has been reported.6 1" He was an insulin-requiring diabetic for the first two years after his acute poisoning, but sufficient islet cell function returned thereafter to permit control of the diabetes by diet alone. His toxic peripheral neuropathy, consisting of severe orthostatic hypotension and pain, also resolved after one year. He never received ergotamine tartrate. Patient 3 permitted an ophthalmoscopic examination. Although there was no optic atrophy, narrowing of vessels, or pigment clumping, there were large areas in the peripheral retina with apparent loss of normal pigmentation. The electroretinograms were bilaterally abnormal (Fig. 3) . The scotopic b wave response to the weaker stimulus was subnormal in amplitude; the implicit time was difficult to measure. The scotopic b wave response to the brighter stimulus consisted solely of an a wave of normal amplitude. The photopic b waves evoked by a 30 Hz flickering light were within normal limits in amplitude and implicit times. RABBIT 
STUDIES
Oral PNU, 125 mg/kg, resulted in loss of the rod portion of the b wave. Administration of two additional doses had little effect on the a wave or on the cone portion of the b wave (Fig. 4) Fig. 4 . The eyes ofthe latter were removed one week after the third oral dose ofPNU, 125 mglkg. The inner retinas ofboth appear normal (SA, B, x330). However, thepigment epithelium ofthe rabbitfed PNUis disrupted. Electron microscopy (SC, D, x2600) demonstrates that thepigment epithelum ofthe PNU-fed rabbit has absence ofphagosomes, nuclei, and cytoplasmic organelles and largefracture areas. Bar is 2-9 pum.
sulphate prevented ERG and histological changes from oral PNU.
Discussion
The initial goal of these studies was to determine whether or not PNU was the probable cause of the progressive pigment retinopathy that developed in patient 1. Among the alternative possibilities were that (1) the large doses of ergotamine tartrate used to Fig. 5C group.bmj.com on June 21, 2017 -Published by http://bjo.bmj.com/ Downloaded from treat the orthostatic hypotension had damaged the RPE; (2) PNU and ergotamine tartrate toxicities were additive; and (3) the patient had hereditary retinitis pigmentosa. Similar large doses of ergotamine had been used to treat orthostatic hypotension and had not been associated with ocular toxicity.'2 13 Ergotamine is less toxic than ergot, and the two reports attributing eye damage to ergotamine ingestion described a papillitis," ' not pigment retinopathy. Nor has ergotamine tartrate overdosage caused ERG abnormalities.'5 On the other hand many cases of PNU poisoning have occurred without any mention being made of ocular abnormalities. Perhaps the eyes had not been adequately examined.
To investigate this possibility, two other PNU survivors were found who had not been treated with ergotamine. Finding subjects willing to participate was difficult. First, most adult PNU ingestions were suicide attempts, and the survivors were reluctant to be reminded of episodes that now embarrassed them. Secondly, survivors who wanted to commit suicide learned quickly that an overdose of the insulin needed to control their PNU-induced diabetes mellitus was an efficient mode of self destruction. The two survivors consenting to have ERG studies had extinguished scotopic b wave responses and mild changes in their a waves. This selectivity for the b wave was also demonstrated in pigmented rabbits fed small doses of PNU. There seemed to be reasonable evidence to conclude that PNU was an ocular toxin. It should be emphasised that it could not be stated that all, or even most, of patients l's abnormal electrophysiological responses and anatomical defects were the direct result of PNU ingestion. Ischaemic hypoxia from her gastrointestinal bleeding, and a possible contributing effect from ergotamine, confounded any attempts to assign causality.
Patient 1 had more severe ocular damage, orthostatic hypotension, and diabetes mellitus than the other two patients despite her ingested dose of PNU having been less, that is, 780 mg (patient 1) versus 3.7 gm (patient 2) and 1-5 gm (patient 3). However, patient 1 did not have emesis or develop diarrhoea after ingesting the poison, while the other two did. She waited 48 hours before going to a hospital emergency room. Presumably her absorbed dose of toxin was larger than those of patients 2 and 3.
PNU appeared to alter the human electroretinogram by preferentially extinguishing the b wave, and in patients 1 and 3 seemed to damage the retinal pigment epithelium. An animal model was needed that would demonstrate similar effects. Rodents were not tested, because they were extremely sensitive to the lethal effects of PNU. Rabbits are lagomorphs and phylogenetically closely related to rodents. Dutch Belted rabbits were chosen because their retinal pigment epithelia were pigmented as was man's. Rabbit eyes are relatively large, allowing the ERG electrodes and equipment designed for use on patients to be easily adapted. When Dutch Belted rabbits were fed PNU, they developed both a selective reduction in the ERG b wave and histological evidence of selective damage to the RPE. This damage to the RPE did not result in an ophthalmoscopically identifiable pigment retinopathy, presumably because the experiments were too short, that is, the rabbits were maintained for no more than three weeks after receiving PNU, while patients 1 and 3 developed pigment retinopathy more than four years after ingesting the poison. Behaviourally, the rabbits' vision did not appear impaired. At the dose of PNU used Dutch Belt rabbits also had a fortuitous absence of diabetes mellitus and peripheral neuropathy. Thus they could be easily maintained.
Oral administration of PNU to rabbits had the potential disadvantage of variable drug absorption from the gastrointestinal tract. More uniform blood and tissue levels should result from parenteral administration. However, intramuscular, retrobulbar, intracarotid artery, and intraperitoneal injections of PNU were without effect. As only oral PNU was toxic, it appeared that the drug had to be metabolised in the gastrointestinal tract to become active, presumably by the bacterial flora. Consistent with this theory was the prophylactic effect of oral gentamicin, a Gram-negative bactericidal antibiotic.
L-Tryptophan was also tested as an antidote. Tryptophan is the amino acid precursor of nicotinamide, a proved antidote of PNU's lethal toxicity in rats.4 Parenteral L-tryptophan did not prevent ocular toxicity from oral PNU. However, oral L-tryptophan did. This suggested that tryptophan was ineffective once the toxic metabolite was absorbed. Oral tryptophan may have competed for the bacterial enzymes that converted PNU or competed for an uptake system responsible for the absorption of the toxic metabolite. 
